Clinical Trial Update: PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension [Phase 4]

View source ↗

Summary

Phase 4 post-marketing surveillance study evaluating the combination of amlodipine and valsartan for essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• amlodipine/valsartan (amlodipine and valsartan)

Snippet

Sponsor: TSH Biopharm Corporation Limited | Conditions: Essential Hypertension | Phase 4 | Status: COMPLETED